When cancer brings questions, clear information can help someone decide what to ask next. GRACE offers free cancer education through videos, live conversations with oncology experts, and resources people can return to at any time.
This year-end, please help us keep those resources free for the next patient and family who need them.
Give to GRACE: cancergrace.org/donate
#AnnualAppeal #GRACE #FreeCancerEducation #GiveToGRACE
What happens in the bone marrow in multiple myeloma?
Myeloma affects plasma cells, the white blood cells that make antibodies to help fight infections. When abnormal plasma cells multiply, they can crowd out healthy blood cells, weaken bones, and affect the kidneys. Many also make an abnormal protein called M protein, which doctors can measure to help track the disease.
Our latest GRACE article explains what these changes mean, how earlier conditions like MGUS and smoldering myeloma are monitored, and what treatment may look like if myeloma comes back.
#MultipleMyeloma #BloodCancer #PatientEducation
Read the article: cancergrace.org/post/multipl…
This Veterans Day, we honor all who have served in the U.S. Armed Forces. To the veterans in the GRACE community and across the country, thank you for your service. We’re also grateful to the families and loved ones who stand beside you. 🇺🇸
#VeteransDay #ThankYouVeterans
Help us give a warm GRACE welcome to our newest board member, Saad Bashir!
Saad brings years of experience helping organizations use technology to serve their communities better. We’re excited to have him on our board as we work to make free, expert-led cancer education easier for patients and caregivers to access.
We’re glad you’re here, Saad!
Get to know Saad at cancergrace.org/staff/saad-b…
#CancerGRACE #CancerEducation #BoardOfDirectors
Bring your questions to Lung Cancer OncTalk 2026. 💙
Join Dr. Alissa Cooper and leading oncologists for patient-centered presentations, expert discussions, and live Q&A.
📅 December 8 & 10
⏰ 7:30–8:45 PM ET
Attend either one or both virtual sessions!
Register: give.cancergrace.org/event/2…
Meet our Lung Cancer OncTalk 2026 faculty! Join Dr. Alissa Cooper and fellow experts to explore lung cancer care and ask questions live.
📅 Dec. 8 & 10 | Free & virtual
Register: give.cancergrace.org/event/2…
#LungCancer #GRACE #NSCLC #SCLC
What’s new in lung cancer treatment? Join @LauraAlderMD at Lung Cancer OncTalk 2026 to explore ADCs, bispecific antibodies, and emerging therapies.
📅 Dec. 8 & 10 | Free & virtual
Register: give.cancergrace.org/event/2…
#LungCancer #NSCLC #ADCsBispecifics
What guides the first lung cancer treatment? Join Dr. @JessieStuart316 at Lung Cancer OncTalk 2026 to explore initial treatment options for NSCLC and SCLC.
📅 Dec. 8 & 10 | Free & virtual
Register: give.cancergrace.org/event/2…
#LungCancer #GRACE #NSCLC #SCLC
How does radiation fit into lung cancer care? Join Dr. Tafadzwa Chaunzwa at Lung Cancer OncTalk 2026 to learn about radiation and coordinated care.
📅 Dec. 8 & 10 | Free & virtual
Register: give.cancergrace.org/event/2…
#LungCancer
An early-stage lung cancer diagnosis: What comes next?
Join Dr. Sarah Waliany at Lung Cancer OncTalk 2026 to learn about key testing and treatment options.
📅 Dec. 8 & 10 | Free & virtual
Register: give.cancergrace.org/event/2…
#LungCancer
3
78
Meet Lung Cancer OncTalk 2026 chair Dr. Alissa Cooper! Join two evenings of lung cancer education and live Q&A.
📅 Dec. 8 & 10
⏰ 7:30–8:45 PM ET
💻 Attend one or both virtual sessions!
Register: give.cancergrace.org/event/2…
#LungCancer #CancerGRACE
Join Lung Cancer OncTalk 2026, led by Dr. Alissa Cooper! Hear about current and emerging treatments and ask experts your questions live.
📅 Session 1: Tuesday, December 8, 2026
📅 Session 2: Thursday, December 10, 2026
⏰ Both sessions: 4:30–5:45 PM PT | 7:30–8:45 PM ET
Attend one or both sessions!
Register: give.cancergrace.org/event/2…
#LungCancer #LiveWebinar
3
62
What is MRD, and what can it tell you about your blood cancer treatment? 🔎
Our patient-friendly article explains measurable residual disease (MRD), how doctors test for it, and what MRD-positive and MRD-negative results may mean.
Explore the basics and find helpful questions to ask your healthcare team.
📖 Read the article: cancergrace.org/post/what-me…
#BloodCancer #MRD #PatientEducation #CancerGRACE
🤖 Made with AI
2
93
Does every lung nodule mean lung cancer—and when does it need surgery?
Following Pope Leo XIV’s lung cancer diagnosis, learn when doctors monitor a lung nodule, recommend a biopsy, or consider surgery.
We explain CT screening, nodule size and growth, and follow-up guidelines.
Follow Larry, a fictional 68-year-old patient, inside illustrated lung tissue, an embedded nodule, and its cells. Learn the difference between screening and nodule follow-up, why biopsy is not always the first step, and which changes can prompt specialist evaluation. The incidental-nodule size guide applies to a single solid nodule in adults 35 or older, outside screening, without known cancer or weakened immunity. Multiple nodules and ground-glass/part-solid nodules follow different pathways. U.S. screening recommendations differ: USPSTF includes a 15-year quitting cutoff; ACS does not.
EPISODE PAGE & LEARNING RESOURCES
youtu.be/9vwuA_EbCxk?si=cdSS…
2
163
💙 Thank you for joining Blood Cancers OncTalk 2026!
To every patient, caregiver, and community member who joined us: thank you for your time, thoughtful questions, and participation.
A heartfelt thank-you to our chair, Dr. Yumeng “Julia” Zhang, and our speakers, Dr. Blue, Dr. Ashwath Gurumurthi, Dr. Supreet Kaur, and Dr. Shivani Handa, for sharing their expertise and making complex topics more accessible to patients and families.
We’re also deeply grateful to our sponsors—Takeda Oncology, Lilly Oncology, Bristol Myers Squibb, and Janssen—for helping make this free educational event possible.
Together, we’re helping more people access trusted cancer education. Thank you for being part of the GRACE community! 💙
#BloodCancer #CancerEducation #GRACE #OncTalk
99
🔴 Another audience question in our live Q&A!
In a patient in their #30s, how do doctors distinguish clonal hematopoiesis of indeterminate potential (CHIP) from polycythemia vera (PV) when there is a JAK2 mutation, persistently high platelets, elevated red blood counts below PV diagnostic thresholds, and a lower-end erythropoietin (EPO) level?
Our panel is discussing this diagnostic question at Blood Cancers OncTalk 2026.
💬 Join us now to hear more! It’s free:
give.cancergrace.org/event/b…
#MPNs #BloodCancer #GRACE #OncTalk
3
151













